Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01031381
Title Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh
Indications

peritoneal carcinoma

ovarian cancer

fallopian tube cancer

Therapies

Bevacizumab + Everolimus

Age Groups: adult
Covered Countries USA


No variant requirements are available.